BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15134485)

  • 1. Drug delivery systems for brain tumor therapy.
    Rautioa J; Chikhale PJ
    Curr Pharm Des; 2004; 10(12):1341-53. PubMed ID: 15134485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma.
    Oberoi RK; Parrish KE; Sio TT; Mittapalli RK; Elmquist WF; Sarkaria JN
    Neuro Oncol; 2016 Jan; 18(1):27-36. PubMed ID: 26359209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives on Dual Targeting Delivery Systems for Brain Tumors.
    Gao H
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):6-16. PubMed ID: 27270720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
    Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.
    Wu L; Li X; Janagam DR; Lowe TL
    Pharm Res; 2014 Mar; 31(3):531-40. PubMed ID: 23996470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches.
    Shah V; Kochar P
    Recent Pat Anticancer Drug Discov; 2018; 13(1):70-85. PubMed ID: 29189177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
    Drapeau A; Fortin D
    Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in drug delivery to tumors of the central nervous system: an overview of pharmacological and surgical considerations.
    Serwer LP; James CD
    Adv Drug Deliv Rev; 2012 May; 64(7):590-7. PubMed ID: 22306489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor.
    Black KL; Ningaraj NS
    Cancer Control; 2004; 11(3):165-73. PubMed ID: 15153840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
    Wang Z; Sun H; Yakisich JS
    Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine.
    Kim M; Kizilbash SH; Laramy JK; Gampa G; Parrish KE; Sarkaria JN; Elmquist WF
    Pharm Res; 2018 Jul; 35(9):177. PubMed ID: 30003344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Drug Delivery via Folate Receptors for the Treatment of Brain Cancer: Can the Promise Deliver?
    Guo J; Schlich M; Cryan JF; O'Driscoll CM
    J Pharm Sci; 2017 Dec; 106(12):3413-3420. PubMed ID: 28842300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors.
    Calabrese G; De Luca G; Nocito G; Rizzo MG; Lombardo SP; Chisari G; Forte S; Sciuto EL; Conoci S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of KATP channels increases anticancer drug delivery to brain tumors and survival.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats T
    Eur J Pharmacol; 2009 Jan; 602(2-3):188-93. PubMed ID: 19027730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood brain barrier: a challenge for effectual therapy of brain tumors.
    Bhowmik A; Khan R; Ghosh MK
    Biomed Res Int; 2015; 2015():320941. PubMed ID: 25866775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.